drugset
drugset / Trial / NCT04812028

Magnesium Sulfate for Analgesia in Pediatric Transplant

NCT04812028 ↗

Phase 2 Completed 66 enrolled University of Minnesota
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To use magnesium sulfate as adjuvant analgesia by implementing a treatment protocol in order to determine whether can benefit pediatric pain in post-operative transplanted patients and decrease overall opioid consumption.

Timeline

Start
2021-03-01
Primary completion
2023-08-10
Completion
2023-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 15 mg/kg Intravenous

Indications

No indication recorded.